Search

Your search keyword '"Cuffe, Sinead"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Cuffe, Sinead" Remove constraint Author: "Cuffe, Sinead" Publication Type Magazines Remove constraint Publication Type: Magazines
29 results on '"Cuffe, Sinead"'

Search Results

1. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

2. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

3. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project

4. Acute kidney Injury due to Alectinib, an Anaplastic Lymphoma Kinase inhibitor

5. A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial

6. Evolution and Clinical Impact of EGFRMutations in Circulating Free DNA in the BELIEF Trial

7. Cancer survivors' experience of OptiMal, a 6-week, occupation-based, self-management intervention

8. Brief Report on the Detection of the EGFRT790M Mutation in Exhaled Breath Condensate from Lung Cancer Patients

9. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

10. Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFRmutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

11. Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial

12. The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?

13. European Epidemiology of Pleural Mesothelioma—Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database

14. Cancer patients’ acceptance, understanding, and willingness-to-pay for pharmacogenomic testing

15. Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin

24. P3.03-021 When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

Catalog

Books, media, physical & digital resources